Cytek Biosciences Inc (CTKB) — Defensive Interval Ratio
Cytek Biosciences Inc (CTKB) has a Defensive Interval Ratio of 1141 days as of March 2026. Defensive assets of $253.04 Million (cash $-, short-term investments $196.56 Million, receivables $56.48 Million) cover 1141 days of daily cash needs of $221.74K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Cytek Biosciences Inc Defensive Interval Ratio (2019–2025)
This chart shows how Cytek Biosciences Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 1141 days, meaning defensive assets of $253.04 Million can fund 1141 days of operations without new revenue. For the complete balance sheet picture, see Cytek Biosciences Inc total assets.
Annual Defensive Interval Ratio for Cytek Biosciences Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Cytek Biosciences Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Cytek Biosciences Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1139 days | $242.80 Million | $213.16K/day | $- | $170.68 Million | ▼ -154 days |
| 2024 | 1293 days | $239.73 Million | $185.38K/day | $- | $179.15 Million | ▲ +311 days |
| 2023 | 982 days | $151.23 Million | $154.04K/day | $- | $95.11 Million | ▲ +272 days |
| 2022 | 710 days | $95.42 Million | $134.36K/day | $- | $44.55 Million | ▲ +384 days |
| 2021 | 326 days | $29.63 Million | $90.91K/day | $- | $0.00 | ▲ +77 days |
| 2020 | 249 days | $18.10 Million | $72.70K/day | $- | $- | ▼ -59 days |
| 2019 | 308 days | $17.75 Million | $57.64K/day | $- | $- | — |